"Umbilical Cord" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The flexible rope-like structure that connects a developing FETUS to the PLACENTA in mammals. The cord contains blood vessels which carry oxygen and nutrients from the mother to the fetus and waste products away from the fetus.
Descriptor ID |
D014470
|
MeSH Number(s) |
A16.378.693
|
Concept/Terms |
Umbilical Cord- Umbilical Cord
- Cord, Umbilical
- Cords, Umbilical
- Umbilical Cords
|
Below are MeSH descriptors whose meaning is more general than "Umbilical Cord".
Below are MeSH descriptors whose meaning is more specific than "Umbilical Cord".
This graph shows the total number of publications written about "Umbilical Cord" by people in this website by year, and whether "Umbilical Cord" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 1 | 0 | 1 |
2017 | 7 | 10 | 17 |
2018 | 8 | 1 | 9 |
2019 | 0 | 1 | 1 |
2020 | 1 | 4 | 5 |
2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Umbilical Cord" by people in Profiles.
-
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev. 2021 08 01; 30(15):758-772.
-
Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge. Stem Cells Dev. 2021 08 01; 30(15):773-781.
-
Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med. 2021 09; 10(9):1279-1287.
-
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia. Stem Cell Res Ther. 2021 06 02; 12(1):316.
-
Umbilical Cord-derived Mesenchymal Stem Cells modulate TNF and soluble TNF Receptor 2 (sTNFR2) in COVID-19 ARDS patients. Eur Rev Med Pharmacol Sci. 2021 Jun; 25(12):4435-4438.
-
Efficacy and safety of umbilical cord mesenchymal stem cells for the treatment of patients with COVID-19. Clinics (Sao Paulo). 2021; 76:e2604.
-
SARS-CoV-2 Infection in Pregnant Women: Neuroimmune-Endocrine Changes at the Maternal-Fetal Interface. Neuroimmunomodulation. 2021; 28(1):1-21.
-
Dodging COVID-19 infection: low expression and localization of ACE2 and TMPRSS2 in multiple donor-derived lines of human umbilical cord-derived mesenchymal stem cells. J Transl Med. 2021 04 14; 19(1):149.
-
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2021 02 10; 6(1):58.
-
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther. 2021 01 29; 12(1):91.